Yasuo Suzuki
-
- Lymphoma Diagnosis and Treatment 9
- Ophthalmology and Eye Disorders 4
- Tea Polyphenols and Effects 4
- Neurology top 10%
- Vestibular and auditory disorders 3
- Ophthalmology top 5%
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities 2
-
- Viral-associated cancers and disorders 8
- Vascular Tumors and Angiosarcomas 3
-
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Mamoru IsemuraNoriyuki MiyoshiMasato HashimotoKenji OhtsukaVolker HennJean A. Büttner‐EnneverAnja K. E. HornK. Hepp
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)The Journal of Comparative Neurology (1 paper)
- Partner nations
- JapanSwitzerlandGermany
In The Last Decade
Yasuo Suzuki
31 papers receiving 765 citations
Peers
Comparison fields: 5 of 104
- Pathology and Forensic Medicine 358
- Neurology 124
- Applied Microbiology and Biotechnology 20
- Ophthalmology 84
- Biochemistry 51
Countries citing papers authored by Yasuo Suzuki
This map shows the geographic impact of Yasuo Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Suzuki more than expected).
Fields of papers citing papers by Yasuo Suzuki
This network shows the impact of papers produced by Yasuo Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Suzuki. The network helps show where Yasuo Suzuki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yasuo Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 22 | |
| 2 | 2018 | 0 | |
| 3 | 2017 | 13 | |
| 4 | 2015 | 42 | |
| 5 | 2014 | 9 | |
| 6 | 2013 | 17 | |
| 7 | 2012 | 0 | |
| 8 | 2011 | 15 | |
| 9 | 2007 | 5 | |
| 10 | 2004 | 34 | |
| 11 | 2004 | 13 | |
| 12 | 2004 | 86 | |
| 13 | 2003 | 5 | |
| 14 | 2003 | 50 | |
| 15 | 1995 | 81 | |
| 16 | 1995 | 75 | |
| 17 | 1995 | 22 | |
| 18 | 1993 | 20 | |
| 19 | 1992 | 20 | |
| 20 | 1979 | 5 |
About Yasuo Suzuki
Yasuo Suzuki is a scholar working on Pathology and Forensic Medicine, Genetics and Applied Microbiology and Biotechnology, having authored 34 papers that have together received 785 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Viral-associated cancers and disorders (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Ophthalmology and Eye Disorders (4 papers), Tea Polyphenols and Effects (4 papers), Vascular Tumors and Angiosarcomas (3 papers), Vestibular and auditory disorders (3 papers) and Phytochemicals and Antioxidant Activities (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (358 citations), Neurology (124 citations) and Applied Microbiology and Biotechnology (20 citations). Yasuo Suzuki has collaborated with scholars based in Japan, Switzerland and Germany. Frequent co-authors include Mamoru Isemura, Noriyuki Miyoshi, Masato Hashimoto, Kenji Ohtsuka, Volker Henn, Jean A. Büttner‐Ennever, Anja K. E. Horn, K. Hepp, V. Henn and Dominik Straumann. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Comparative Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.